National Longitudinal Cohort of Hematological Diseases — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

National Longitudinal Cohort of Hematological Diseases — Stella

Home/Multiple Myeloma/

View on ClinicalTrials.gov

Recruiting

Back to Multiple Myeloma trials

Trial locations(1 site)

China

Institute of Hematology & Blood Diseases Hospital, Tianjin, Tianjin Municipality

Key details

Sponsor

Institute of Hematology & Blood Diseases Hospital, China

Enrollment target

~2,300 participants

Started

December 2020

Primary completion

December 2030

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.